#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal adenocarcinoma Pulmonary arterial hypertension Acute myeloid leukaemia Chronic graft versus host disease in intestine Follicular lymphoma stage III Adenocarcinoma pancreas Metastases to peritoneum Subdural haematoma Wiskott-Aldrich syndrome Nephroblastoma Conjunctivitis allergic Primary adrenal insufficiency Hypoxic-ischaemic encephalopathy Anti-myelin-associated glycoprotein associated polyneuropathy Neuroblastoma More trials…

    Learn about Rare Diseases

    Ocular melanoma – Life with Disease Stevens-Johnson syndrome – Basic Information Glycogen storage disease type I – Trials in Disease Primary hyperoxaluria Lymphangioma – Trials in Disease Hepatic angiosarcoma – Trials in Disease Chondrosarcoma – Treatment Ewing’s sarcoma – Life with Disease Haemophilia A with anti factor VIII – Basic Information Progressive supranuclear palsy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Insulin Lispro Ifezuntirgene Inilparvovec Rp1 Corylus Avellana L. Carvedilol Etripamil Arachis Hypogaea (762) Rp-1664 Sulfate Deupirfenidone Copanlisib Dihydrochloride Mannitol Dobutamine Rozanolixizumab Dimethyl Fumarate Sodium Iodide (123 I) Lasofoxifene Human Coagulation Factor X Edotreotide 4-Hydroxy-N-Desmethyltamoxifen Adg126 More therapies…

    Learn about Your Condition

    Adrenal insufficiency Proteinuria Hairy cell leukaemia Sepsis Pulmonary sarcoidosis Chronic kidney disease Endocarditis enterococcal Skin papilloma Obesity Gastric cancer Graft versus host disease Mitral valve prolapse Medulloblastoma recurrent Influenza Infertility male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Dexamethasone
    • Elranatamab
    Finland France Greece Italy The Netherlands Norway

  • Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Czechia Denmark Greece Hungary Italy Poland +1

  • Study on MK-6194 for Adults with Systemic Lupus Erythematosus

    Not recruiting

    4 1
    Investigated Drugs:
    • Mk-6194
    France Italy Poland Spain

  • Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • Sebetralstat
    Austria Bulgaria France Germany Greece Hungary +7

  • Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    Austria Belgium Bulgaria Croatia France Germany +5

  • Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    • Primary myelofibrosis
    Investigated Drugs:
    • Luspatercept
    • Sodium Chloride
    Austria Belgium Czechia France Germany Greece +6

  • Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Obinutuzumab
    Austria Czechia France Germany Italy The Netherlands +3

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Azilsartan Medoxomil
    • Candesartan
    • Captopril
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rosnilimab
    Belgium Estonia France Germany Hungary Italy +3

  • Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

    Not recruiting

    2 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Gsk4532990A
    Belgium France Greece Italy Spain
Previous Page
1 … 29 30 31 32 33 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!